Businesses for Sale

An online platform to buy diamonds, based in Barcelona, Spain. - We accept more than 60 cryptocurrencies. . - We have 10 certified suppliers of diamonds from Belgium and India. All diamonds listed on our platform are certified and have a code attached to them from leading diamond labs in the world. - Have over 10,000 diamonds listed. All are listed with their certifications, images and price trends. - Users can purchase these diamonds and have it home delivered to them. - We offer a buy-back option to customers where we purchase the diamonds back from them at market price (Wholesale price). - All diamond transactions (buy and sell) are based on wholesale prices of the diamonds. - Have sold to customers across 4 countries till date. - Diamonds are not owned by our company. We charge a commission on the transaction to the supplier. - Business does not own any physical assets. - CEO has 24 years of experience working in the wholesale diamonds market.

Online e-commerce platform that has stopped operations since the last 2 years. - We used to sell ethnic, western, trendy apparel for men, women and kids. - Started the company 5 years ago and our platform used to receive good traffic. - We used to receive more than 20 orders per day when operational. - Company has zero debt / liability. - Promoters have 15 years of experience in the IT industry and have worked in one of the Fortune 100 companies. - Buyer would get the complete business with E-commerce platform, source codes, clients and vendors details.

Online e-commerce platform that has stopped operations since the last 2 years. - We used to sell ethnic, western, trendy apparel for men, women and kids. - Started the company 5 years ago and our platform used to receive good traffic. - We used to receive more than 20 orders per day when operational. - Company has zero debt / liability. - Promoters have 15 years of experience in the IT industry and have worked in one of the Fortune 100 companies. - Buyer would get the complete business with E-commerce platform, source codes, clients and vendors details.

Pharma marketing business involved in the marketing, branding, and supplying of ophthalmic medicines. - Our customers are doctors. - We own the brand names, where we have 'R' for 2 brands and 'TM' for our other brand names. - Buyer gets the legal entity, the brand trademarks, and the stock of medicines and other physical assets. - Operating since November five years back with all approved papers.

Located in Pimpri-Chinchwad, this pharma marketing business specializes in tailored solutions for the pharmaceutical and chemical manufacturing sectors. - The company procures and markets products, primarily enhancing brand visibility and accessibility within the pharma and chemical industries. - Partnerships with over 15 esteemed clients, including Cipla, Emcure, and Thermax, highlight the business's strong market presence and reliability. - As a channel partner for respected brands like Merck and Sigma-Aldrich, the company boosts its credibility within the scientific community. - Revenue is generated through the procurement and resale of pharmaceutical, chemical, and laboratory products to pharmaceutical and chemical manufacturers, R&D laboratories, and academic institutions. - Their primary customers are pharmaceutical and chemical manufacturers, research labs, and academic institutions in the Hinjewadi region of Pune. - With established relationships and competitive pricing, the company ensures reliable supply chain solutions, fostering customer loyalty. - The strategic location in Pune positions the business to capitalize on the increasing demand for innovative solutions from local research and manufacturing entities.

Cutting-edge SaaS platform revolutionizing the homecare industry through AI-driven automation and seamless integrations. Designed to meet the needs of homecare agencies and franchise networks, the business simplifies complex operations, improves service quality, and ensures compliance with industry mandates like EVV. Developed over the past five years with experts in the U. S. homecare industry, this proven, HIPAA-compliant platform has been used by over 15 agencies of a leading homecare franchise based in Idaho. Market Potential: The global homecare market, valued at $100 billion in 2023, is projected to grow at an annual rate of 7-9%. With over 450,000 agencies worldwide and an addressable market of $1.2 billion in the U. S. alone, the business is strategically positioned to capitalize on this growth. Core Features: • AI-Powered Caregiver Assignment: Optimizes resource utilization by matching caregivers with clients. • Comprehensive Billing and RCM Support: Streamlines financial operations with real-time updates, minimizing errors. • Actionable Analytics: Dashboards and insights for data-driven decisions. • Franchise Management: Tools for franchisor-franchisee compliance, performance tracking, and unified branding. • Customizable Workflows: Tailored to meet unique agency requirements for scalability. Revenue Streams: • Subscription Plans: Tiered pricing for agencies of all sizes. • Add-On Services: Custom integrations and advanced analytics. • Transaction Fees: Billing and payment processing. • Franchise Modules: Dedicated features for franchise operations. Competitive Edge: The business outshines competitors like AlayaCare and ClearCare with: • AI-driven caregiver assignments. • End-to-end billing solutions. • Franchise-specific management tools. • Cost-effective scalability for small to enterprise-level agencies. • Technology Excellence. O Built on robust technologies like Java Spring Boot, Angular, MySQL, and Docker, the platform ensures reliability, security, and compliance, including HIPAA standards. It integrates seamlessly with tools like Twilio, Stripe, QuickBooks, and more. Growth Potential: • Short-Term: Target small and mid-sized agencies. • Medium-Term: Expand franchise-specific capabilities. • Long-Term: Enter international markets with region-specific customizations. Unique Selling Proposition (USP): The business delivers intelligent automation, comprehensive billing, and analytics, all while supporting franchises and scaling to meet the demands of growing agencies. - The platform no longer has any active customers and when it was operating its last reported annual revenue was of INR 75 lakh. - Buyer will not get the private limited entity that owns and operates this software product.

Located in Vijayawada, this pharma marketing company is positioned in a region that serves as a significant pharmaceutical hub in India. - Specializes in high-demand medical areas such as Orthopedics, Neurology, and IVF, ensuring a strong market niche and potential for growth. - Operates with a lean team of 13 employees, optimizing operational efficiency and minimizing overhead costs. - Maintains robust relationships with 120 doctors, providing a reliable and consistent channel for product distribution and strong business alliances. - Employs third-party manufacturing processes with facilities that hold a GMP (Good Manufacturing Practice) certification, ensuring high-quality production standards. The business has a valid GST certificate. - The company benefits from a strong network within the pharmaceutical industry, paving the way for strategic partnerships and collaborations.

This business is a well-established pharmaceutical manufacturing company with 30 years of industry experience. - It specializes in the development, manufacturing, and marketing of high-quality finished formulations under its own brand names. - The company supplies its products primarily to distributors and retailers, which form the bulk of its customer base. - It generated a steady annual revenue of INR 5 crore, with an EBITDA margin of 3% last year, indicating consistent financial performance. - Sales have shown positive growth with recent monthly sales figures of INR 40 to 50 lakh over the last 2 months, compared to the prior annual sales. - The owner is seeking complete business acquisition, driven by the inability to manage operations due to personnel shortage. - The company holds important industry certifications such as ISO and GMP, along with GST registration, ensuring compliance with high manufacturing and quality standards.

The business operates in the pharmaceutical marketing industry, with a focus on cardiology and diabetes medicines. It has a strong local distribution network in the city of Indore. - The company has a portfolio of 55 products, including capsules, tablets, injections, and syrups. Its major clients are local private hospitals, and the company maintains a 3-month advance stock of its products. - The business operates in Madhya Pradesh and Rajasthan, with an outsourced manufacturing model. Once the products are manufactured, the company is responsible for marketing them to the public. - The company has about 10 employees and operates with two distributors in every town, ensuring a robust distribution network. - The business holds 20B and 21B licenses, and the manufacturing company is WHO GMP certified, ensuring adherence to global quality standards. - The business has a strong presence in the pharmaceutical market in Indore, with a focus on serving local private hospitals and maintaining a consistent stock of products. - The company's focus on cardiology and diabetes medicines, along with its strong distribution network, positions it well for potential growth within the pharmaceutical marketing industry.

Located in Paonta Sahib, the business operates a pharmaceutical manufacturing plant specializing in liquid, capsule, and ointment formulations. - The company provides third-party manufacturing services for pharma, nutraceuticals and health supplement brands, catering to a growing demand for health-related products. - It sells its products primarily to wholesalers across India, establishing partnerships with 20-30 wholesalers to ensure wide distribution. - The production capacity of the facility includes the ability to manufacture up to 20,000 bottles of syrup per shift, ensuring efficient output and timely deliveries. - The business is compliant with regulatory standards, holding both FSSAI and drug licenses, which bolsters its credibility in the pharmaceutical industry.